Related Articles
Vascular cell-derived fibrinolytic regulators and atherothrombotic vascular disorders (Review).
The immune landscape of hepatocellular carcinoma‑where we are? (Review)
Prothrombotic status in COVID‑19 with diabetes mellitus (Review)
The tumor microenvironment in hepatocellular carcinoma (Review)
Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review)